Over the past decade, Slovenia's insulin dosage market value per capita has shown a declining trend. In 2023, the value stood at $16.43, marking a steady decrease from previous years. The year-on-year variation indicates slight declines each year, with the most significant changes occurring between 2019 and 2020, and 2020 and 2021.
Notably, the Compound Annual Growth Rate (CAGR) over the last five years (2018 to 2023) reflects a consistent annual reduction in the market value.
Future trends to watch include advancements in diabetes management technology, potential policy changes affecting pricing and reimbursement, and shifts in demographic health needs that could impact market demand in Slovenia.
| # | 22 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 29.7 | 2023 | View data | ||
| 2 | 2 United Kingdom | 27.44 | 2023 | View data | ||
| 3 | 3 Greece | 26.06 | 2023 | View data | ||
| 4 | 4 Netherlands | 24.72 | 2023 | View data | ||
| 5 | 5 Belgium | 21.98 | 2023 | View data | ||
| 10 | 10 Spain | 18.61 | 2023 | View data | ||
| 11 | 11 New Zealand | 16.5 | 2023 | View data | ||
| 12 | 12 Slovenia | 16.43 | 2023 | |||
| 13 | 13 Slovakia | 13.6 | 2023 | View data | ||
| 14 | 14 Japan | 13.48 | 2023 | View data | ||
